Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
February 2007
Sun Mon Tue Wed Thu Fri Sat
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28
Saskatchewan Winters Last updated: Mon 04 Feb 2008 11:19 PM CST
Saskatchewan Blizzard
View Article  Harnessing Brain's Plasticity Key to Treating Neurological Damage

Harnessing Brain's Plasticity Key to Treating Neurological Damage

The need for strategies that treat complex neurological impairments has never been greater.

One tack being pursued ...   more »

View Article  Health-related quality of life in a population-based sample of people with multiple sclerosis in Stockholm County.

Health-related quality of life in a population-based sample of people with multiple sclerosis in Stockholm County.

 

Department of Clinical Neuroscience,

Division of Neurology,

Karolinska ...   more »

View Article  Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in MS

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in MS

 

Oxford Centre for Enablement,

Windmill Road,

Oxford OX3 ...   more »

View Article  scope and nature of pain in persons with MS

The scope and nature of pain in persons with multiple sclerosis.

 

Department of Rehabilitation Medicine,

Box 359740,

325 9th Avenue,

University of Washington School ...   more »

View Article  continuous combined therapy with beta-interferon 1a, prednisone, and azathioprine.

Serum immunologic markers in multiple sclerosis patients on continuous combined therapy with beta-interferon 1a, prednisone, and azathioprine.

 

Indiana Center for Multiple Sclerosis and Neuroimmunopathologic ...   more »

View Article  Disease evolution in multiple sclerosis.

 

Disease evolution in multiple sclerosis.

 

University Dept.  of Clinical Neurology,

Radcliffe Infirmary,

Woodstock Road,

Oxford OX2 6HE,

United Kingdom,

 

Multiple sclerosis ...   more »

View Article  Cervical cord magnetization

Cervical cord magnetization transfer ratio and clinical changes over 18 months in patients with RRMS: a preliminary study.

 

Department of Neurology,

Neuroimaging Research Unit, ...   more »

View Article  Glatiramer acetate in primary progressive multiple sclerosis:

Glatiramer acetate in primary progressive multiple sclerosis:

 

Results of a multinational, multi-center, double-blind, placebo-controlled trial.


 OBJECTIVE:

 

To determine whether glatiramer acetate (GA) ...   more »

View Article  Improvements in muscle-tendon properties are beneficial to balance in MS.

Improvements in muscle-tendon properties are beneficial to balance in MS.

 

 

Institute for Biophysical and Clinical Research into Human Movement,

Manchester Metropolitan University,

Hassall ...   more »

View Article  comparison of interferon beta therapies for RRMS.

A comparison of interferon beta therapies for RRMS.
 

Dept. of Neurology,

Cologne City Hospitals,

University of Colognen, Ostmerheimerstr. 200, 51109,

Cologne, Germany


Interferon beta ...   more »

View Article  Information about Naltrexone

Naltrexone

(nal trex' one)

From:

SafeMedication.com


Other Names:ReVia
Important Warning

Large doses of naltrexone may cause liver failure. Tell your doctor if you have ...   more »

View Article  Patient Advocates With MS Fund Clinical Trial

Patient Advocates With MS Fund Clinical Trial Of 
Promising Drug That Has Already Helped Thousands

Over the last decade, anecdotal reports suggested that a very ...   more »

View Article  MS: Extent of Brain Involvement at Diagnosis May Predict Later Brain Atrophy

MS: Extent of Brain Involvement at Diagnosis May Predict Later Brain 
Atrophy

CHICAGO, IL -- February 13, 2007 -- In patients with recently 
diagnosed multiple ...   more »

View Article  video - Tysabri

An MS Drug Back on the Market

 

After being suspended from the market for safety reasons, natalizumab is again available for the treatment of ...   more »

View Article  SRI to Evaluate Drug for Treatment of Multiple Sclerosis

SRI to Evaluate Drug for Treatment of Multiple Sclerosis and Other Disorders Such as Rheumatoid Arthritis and Atherosclerosis

 

SRI International and Telik Announce Exclusive ...   more »